Skip to content
DraconiticResearch
Search Sources API
220,430 studies31 sourcesUpdated 46 min ago
Peer-reviewedCC BY-NC-ND 4.0Journal of the National Cancer Center

Premature cancer mortality in China based on cancer registry☆

  • Bingfeng Han1
  • Rongshou Zheng1
  • Hongmei Zeng1
  • Shaoming Wang1
  • Kexin Sun1
  • Ru Chen1
  • Li Li1
  • Meicen Liu1
  • Wanqing Chen1
  • Wenqiang Wei2
  • Jie He3
  1. 1Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  2. 2Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  3. 3Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Read full textDOICite

Abstract

Background: The “Healthy China 2030” outline aims to reduce premature mortality from major non-communicable diseases by 30% by 2030 compared to the levels in 2015. In China, approximately 2.57 million cancer-related deaths occurred in 2022. Population-based cancer registries are crucial for assessing cancer burdens and guiding policy. The National Cancer Center (NCC) of China regularly collects cancer registry data, ensures quality control and reports the nationwide statistics on cancer mortality in China.

Methods: Data from 1073 cancer registries in China were submitted to the NCC in 2019. Quality control was conducted based on Chinese and international guidelines. Temporal trends in premature mortality rates from 2010 to 2019 were analyzed using data from 106 continuous cancer registries representing 8.85% of the Chinese population. Descriptive analysis, standardized mortality rates, and Joinpoint Regression were used to examine cancer-related deaths stratified by sex and area.

Results: In 2019, the premature mortality rate from cancer in China was 6.67%. Lung cancer had the highest premature mortality rate (1.87%), followed by liver cancer (1.15%). In South China, liver cancer had the highest premature mortality rate, while lung cancer led in other regions. Nasopharyngeal cancer had a higher premature mortality rate in South China. From 2010 to 2019, a significant decreasing trend of 1.9% per year was observed in premature cancer mortality, primarily due to declines in esophageal, stomach, and liver cancers.

Conclusions: Premature cancer mortality remains a significant issue in China, with lung cancer being the leading cause. Traditionally high-incidence digestive tract cancers in China still carried a substantial burden of premature mortality. Throughout the history of cancer prevention and control, there has been a notable decline in overall premature cancer mortality, particularly for cancers of the digestive tract. In the future, it is imperative to develop tailored screening, early diagnosis, and early treatment strategies for different cancers in order to achieve the goal of reducing premature cancer mortality and enhancing the health of the population.

Related

  1. Machine learning for predicting mortality in women diagnosed with breast cancer in the State of Mato Grosso, Brazil using linked population-based cancer registry and mortality data
    Sancho Pedro Xavier, Audêncio Victor, Ana Raquel Ernesto Manuel Gotine +6
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  2. Assessing mortality risk in colorectal cancer survivors with congestive heart failure: a cohort study from the Taiwan Cancer Registry.
    Mitsuhiro Koseki, Ching-Chieh Yang, I-Che Feng +5
    BMC cancerPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  3. Sex- and Region-Specific Incidence and Mortality Trends in Laryngeal and Oropharyngeal Cancer: A 95,000-Case Population-Based Registry Analysis from Poland, 1999–2023
    Mariusz Kiszka, Małgorzata Wierzbicka, Wioletta Pietruszewska +2
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  4. Discharge preparation experiences of intergenerational caregivers for premature infants in China's NICU: a qualitative study.
    Sijia Shen, Ling Jiang, Yuelan Ma +2
    BMJ paediatrics openPeer-reviewedCC BY-NCFull textObstetrics, gynaecology & paediatricsEurope PMC
  5. Cancer incidence and mortality in China, 2024
    Rongshou Zheng, Kexin Sun, Bingfeng Han +8
    Journal of the National Cancer CenterPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC

Cite

BibTeXRIS
BibTeX
@article{han2026premature,
  title = {{Premature cancer mortality in China based on cancer registry☆}},
  author = {Bingfeng Han and Rongshou Zheng and Hongmei Zeng and Shaoming Wang and Kexin Sun and Ru Chen and Li Li and Meicen Liu and Wanqing Chen and Wenqiang Wei and Jie He},
  journal = {Journal of the National Cancer Center},
  year = {2026},
  month = aug,
  doi = {10.1016/j.jncc.2026.07.006},
  url = {https://doi.org/10.1016/j.jncc.2026.07.006},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Premature cancer mortality in China based on cancer registry☆
AU  - Bingfeng Han
AU  - Rongshou Zheng
AU  - Hongmei Zeng
AU  - Shaoming Wang
AU  - Kexin Sun
AU  - Ru Chen
AU  - Li Li
AU  - Meicen Liu
AU  - Wanqing Chen
AU  - Wenqiang Wei
AU  - Jie He
PY  - 2026
DA  - 2026/08/27
JO  - Journal of the National Cancer Center
DO  - 10.1016/j.jncc.2026.07.006
UR  - https://doi.org/10.1016/j.jncc.2026.07.006
AB  - Background: The “Healthy China 2030” outline aims to reduce premature mortality from major non-communicable diseases by 30% by 2030 compared to the levels in 2015. In China, approximately 2.57 million cancer-related deaths occurred in 2022. Population-based cancer registries are crucial for assessing cancer burdens and guiding policy. The National Cancer Center (NCC) of China regularly collects cancer registry data, ensures quality control and reports the nationwide statistics on cancer mortality in China.  Methods: Data from 1073 cancer registries in China were submitted to the NCC in 2019. Quality control was conducted based on Chinese and international guidelines. Temporal trends in premature mortality rates from 2010 to 2019 were analyzed using data from 106 continuous cancer registries representing 8.85% of the Chinese population. Descriptive analysis, standardized mortality rates, and Joinpoint Regression were used to examine cancer-related deaths stratified by sex and area.  Results: In 2019, the premature mortality rate from cancer in China was 6.67%. Lung cancer had the highest premature mortality rate (1.87%), followed by liver cancer (1.15%). In South China, liver cancer had the highest premature mortality rate, while lung cancer led in other regions. Nasopharyngeal cancer had a higher premature mortality rate in South China. From 2010 to 2019, a significant decreasing trend of 1.9% per year was observed in premature cancer mortality, primarily due to declines in esophageal, stomach, and liver cancers.  Conclusions: Premature cancer mortality remains a significant issue in China, with lung cancer being the leading cause. Traditionally high-incidence digestive tract cancers in China still carried a substantial burden of premature mortality. Throughout the history of cancer prevention and control, there has been a notable decline in overall premature cancer mortality, particularly for cancers of the digestive tract. In the future, it is imperative to develop tailored screening, early diagnosis, and early treatment strategies for different cancers in order to achieve the goal of reducing premature cancer mortality and enhancing the health of the population.
SN  - 2096-8663
SN  - 2667-0054
ER  -